DrugCite
Search

STOCRIN

Adverse Events
Drug Profile
Learn More
Reference
About Results
Comments

Stocrin Adverse Events Reported to the FDA Over Time

How are Stocrin adverse event reports trending over time?

This graph shows volume of adverse events submitted to the FDA by quarter for Stocrin, as well as related generic and/or brandname drugs containing the same primary active ingredients. Adverse events are counted if Stocrin is flagged as the suspect drug causing the adverse event.

Most Common Stocrin Adverse Events Reported to the FDA

What are the most common Stocrin adverse events reported to the FDA?

Pregnancy
53 (2.63%)
Pyrexia
47 (2.34%)
Immune Reconstitution Syndrome
33 (1.64%)
Neurodevelopmental Disorder
33 (1.64%)
Liver Disorder
30 (1.49%)
Rash
30 (1.49%)
Drug Exposure During Pregnancy
27 (1.34%)
Vomiting
26 (1.29%)
Aspartate Aminotransferase Increase...
25 (1.24%)
Alanine Aminotransferase Increased
24 (1.19%)
Suicide Attempt
24 (1.19%)
Show More Show More
Depressed Level Of Consciousness
22 (1.09%)
Anaemia
20 (.99%)
Nausea
20 (.99%)
Proteinuria
20 (.99%)
Diarrhoea
19 (.94%)
Gamma-glutamyltransferase Increased
19 (.94%)
Hypokalaemia
18 (.89%)
Abdominal Pain
17 (.84%)
Malaise
17 (.84%)
Blood Alkaline Phosphatase Increase...
16 (.8%)
Blood Lactate Dehydrogenase Increas...
16 (.8%)
Death
15 (.75%)
Diabetes Mellitus
15 (.75%)
Drug Eruption
15 (.75%)
Dyspnoea
15 (.75%)
Insomnia
15 (.75%)
Renal Impairment
14 (.7%)
Headache
13 (.65%)
Hepatic Encephalopathy
13 (.65%)
Hepatic Failure
13 (.65%)
Hepatic Function Abnormal
13 (.65%)
Hepatitis Fulminant
13 (.65%)
Abortion Induced
12 (.6%)
Lactic Acidosis
12 (.6%)
Weight Decreased
12 (.6%)
Intentional Overdose
11 (.55%)
Lipodystrophy Acquired
11 (.55%)
Mycobacterium Avium Complex Infecti...
11 (.55%)
Arthritis
10 (.5%)
Asthenia
10 (.5%)
Blood Bilirubin Increased
10 (.5%)
Cytomegalovirus Chorioretinitis
10 (.5%)
Depression
10 (.5%)
Hyperlipidaemia
10 (.5%)
Hypoaesthesia
10 (.5%)
Hyponatraemia
10 (.5%)
Overdose
10 (.5%)
Renal Disorder
10 (.5%)
White Blood Cell Count Decreased
10 (.5%)
Ascites
9 (.45%)
C-reactive Protein Increased
9 (.45%)
Glaucoma
9 (.45%)
Hypertriglyceridaemia
9 (.45%)
Jaundice
9 (.45%)
Pancytopenia
9 (.45%)
Parkinsonism
9 (.45%)
Renal Failure
9 (.45%)
Renal Failure Acute
9 (.45%)
Uveitis
9 (.45%)
Blood Glucose Increased
8 (.4%)
Cerebral Haemorrhage
8 (.4%)
Decreased Appetite
8 (.4%)
Drug Interaction
8 (.4%)
Duodenal Stenosis
8 (.4%)
Fatigue
8 (.4%)
Haemoglobin Decreased
8 (.4%)
Pneumocystis Jiroveci Pneumonia
8 (.4%)
Pruritus
8 (.4%)
Pulmonary Tuberculosis
8 (.4%)
Somnolence
8 (.4%)
Spastic Paraplegia
8 (.4%)
Spinal Cord Disorder
8 (.4%)
Vitamin B12 Deficiency
8 (.4%)
White Blood Cell Count Increased
8 (.4%)
Bone Marrow Failure
7 (.35%)
Dermatitis Exfoliative
7 (.35%)
Disseminated Intravascular Coagulat...
7 (.35%)
Fall
7 (.35%)
Haematuria
7 (.35%)
Lymphoma
7 (.35%)
Nephrotic Syndrome
7 (.35%)
Platelet Count Decreased
7 (.35%)
Subacute Combined Cord Degeneration
7 (.35%)
Toxic Skin Eruption
7 (.35%)
Aids Encephalopathy
6 (.3%)
Blood Lactic Acid Increased
6 (.3%)
Coma
6 (.3%)
Cough
6 (.3%)
Dehydration
6 (.3%)
Dialysis
6 (.3%)
Disease Progression
6 (.3%)
Dizziness
6 (.3%)
Drug Resistance
6 (.3%)
Erythema
6 (.3%)
Herpes Zoster
6 (.3%)
Hypoalbuminaemia
6 (.3%)
Malnutrition
6 (.3%)
Multiple Drug Overdose Intentional
6 (.3%)
Normochromic Normocytic Anaemia
6 (.3%)
Oedema Peripheral
6 (.3%)

ExportShare/Embed GraphExport Export Data

This graph shows the top adverse events submitted to the FDA for Stocrin, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Stocrin is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.

Adverse Event Categories for Stocrin

What are the most common Stocrin adverse events reported to the FDA?

Show More Show More

ExportShare/Embed Graph Export Export Data

This graph shows the top categories of adverse events submitted to the FDA for Stocrin, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Stocrin is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.

Common Uses of Stocrin According to Those Reporting Adverse Events

Why are people taking Stocrin, according to those reporting adverse events to the FDA?

Hiv Infection
671
Acquired Immunodeficiency Syndrome
111
Drug Use For Unknown Indication
20
Antiretroviral Therapy
9
Infection
4
Antiviral Treatment
3
Show More Show More
Acute Hiv Infection
3
Hiv Test Positive
3
Hiv Infection Cdc Category C3
1
Product Used For Unknown Indication
1
Drug Exposure During Pregnancy
1
Systemic Antiviral Treatment
1
Vertical Infection Transmission
1
Lung Neoplasm Malignant
1
Platelet Aggregation Inhibition
1
Hepatitis B Virus
1

Stocrin Case Reports

What Stocrin safety concerns are being reported by doctors and researchers in the medical literature?

Powered by Google

About Results

This report contains aggregated drug side effects and adverse events for Stocrin. The data has been pulled from the United States Food and Drug Administration's (US FDA) Adverse Event Reporting System (AERS), a database containing more than 4,000,000 adverse event reports.

DrugCite expands your query using the Unified Medical Language System (UMLS) to include generic drugs and primary active ingredients. While the core of DrugCite's advanced drug filtering algorithm is based on the industry standard UMLS, DrugCite's proprietary filtering system also includes dozens of additional steps to reconcile malformed drug names in the FDA's data.

DrugCite only counts a drug if the submitter of the adverse event indicates that the drug is suspected to have caused the adverse event.

Depending on how the data is aggregated, different counts may occur. When someone submits an adverse event to the FDA, the submitter can attribute multiple adverse events to one or more drugs. For example, an individual taking Paxil could submit the adverse events "anxiety" and "suicidal ideation" for the same individual safety report (ISR). This means when DrugCite aggregates by adverse event, two distinct adverse events are counted in the adverse event graph; once for "anxiety" and again for "suicidal ideation". However, when DrugCite aggregates by individual safety reports irrespective of the details of the adverse events contained within the safety report, the report is only counted once.

Comments

Share your experience with Stocrin.